ES2034117T3 - Formulacion de unguento con esteroide. - Google Patents
Formulacion de unguento con esteroide.Info
- Publication number
- ES2034117T3 ES2034117T3 ES198888118871T ES88118871T ES2034117T3 ES 2034117 T3 ES2034117 T3 ES 2034117T3 ES 198888118871 T ES198888118871 T ES 198888118871T ES 88118871 T ES88118871 T ES 88118871T ES 2034117 T3 ES2034117 T3 ES 2034117T3
- Authority
- ES
- Spain
- Prior art keywords
- beta
- alpha
- propylene glycol
- steroid
- impart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003431 steroids Chemical class 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 6
- 239000002674 ointment Substances 0.000 abstract 3
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 abstract 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- DXEXNWDGDYUITL-FXSSSKFRSA-N Tipredane Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@@](SC)(SCC)[C@@]1(C)C[C@@H]2O DXEXNWDGDYUITL-FXSSSKFRSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 abstract 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 abstract 1
- 229940073669 ceteareth 20 Drugs 0.000 abstract 1
- 229940081733 cetearyl alcohol Drugs 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 239000003974 emollient agent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 150000004668 long chain fatty acids Chemical class 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 abstract 1
- 239000001508 potassium citrate Substances 0.000 abstract 1
- 229960002635 potassium citrate Drugs 0.000 abstract 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 abstract 1
- 235000011082 potassium citrates Nutrition 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract 1
- 229940001584 sodium metabisulfite Drugs 0.000 abstract 1
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000002562 thickening agent Substances 0.000 abstract 1
- 229950001669 tipredane Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/120,276 US4868168A (en) | 1987-11-13 | 1987-11-13 | Steroid ointment formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2034117T3 true ES2034117T3 (es) | 1993-04-01 |
Family
ID=22389282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198888118871T Expired - Lifetime ES2034117T3 (es) | 1987-11-13 | 1988-11-11 | Formulacion de unguento con esteroide. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4868168A (enExample) |
| EP (1) | EP0316815B1 (enExample) |
| JP (1) | JPH01153641A (enExample) |
| AT (1) | ATE76576T1 (enExample) |
| CA (1) | CA1326448C (enExample) |
| DE (1) | DE3871494D1 (enExample) |
| ES (1) | ES2034117T3 (enExample) |
| GR (1) | GR3005443T3 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883660A (en) * | 1988-10-17 | 1989-11-28 | Thames Pharmacal Co., Inc. | Gel bases for pharmaceutical compositions |
| DE59108924D1 (de) * | 1991-07-16 | 1998-02-19 | Schering Ag | Verfahren zur herstellung von mikronisierte wirkstoffe enthaltende halbfeste zubereitungen |
| ES2385737T3 (es) * | 2004-11-10 | 2012-07-31 | Hisamitsu Pharmaceutical Co., Inc. | Fármaco para uso externo y parche adhesivo |
| WO2008106646A2 (en) * | 2007-03-01 | 2008-09-04 | Introgen Therapeutics, Inc | Methods and formulations for topical gene therapy |
| JP5781443B2 (ja) * | 2009-01-16 | 2015-09-24 | ネオキュティス エスアー | 皮膚色素沈着の障害および状態を処置するカルシウム封鎖組成物および方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2801202A (en) * | 1954-12-24 | 1957-07-30 | Smith Kline French Lab | Compositions containing cortisone or hydrocortisone with phenylephrine |
| US3592930A (en) * | 1968-07-19 | 1971-07-13 | Syntex Corp | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle |
| GB1382614A (en) * | 1972-01-10 | 1975-02-05 | Squibb & Sons Inc | Steroid compositions |
| US4048310A (en) * | 1976-02-24 | 1977-09-13 | E. R. Squibb & Sons, Inc. | Topical steroid formulation in form of lotion or cream |
| US4233295A (en) * | 1979-05-31 | 1980-11-11 | E. R. Squibb & Sons, Inc. | Corticosteroid formulations containing sebacate carrier |
| NZ200918A (en) * | 1981-07-02 | 1985-07-31 | Gist Brocades Nv | Stable fatty oil-in-water emulsion cream for topical application |
| US4361559A (en) * | 1981-08-20 | 1982-11-30 | E. R. Squibb & Sons, Inc. | Antiinflammatory 17,17-bis (substituted thio) androstenes |
-
1987
- 1987-11-13 US US07/120,276 patent/US4868168A/en not_active Expired - Fee Related
-
1988
- 1988-10-12 CA CA000579960A patent/CA1326448C/en not_active Expired - Lifetime
- 1988-11-11 EP EP88118871A patent/EP0316815B1/en not_active Expired - Lifetime
- 1988-11-11 ES ES198888118871T patent/ES2034117T3/es not_active Expired - Lifetime
- 1988-11-11 JP JP63286603A patent/JPH01153641A/ja active Pending
- 1988-11-11 DE DE8888118871T patent/DE3871494D1/de not_active Expired - Lifetime
- 1988-11-11 AT AT88118871T patent/ATE76576T1/de not_active IP Right Cessation
-
1992
- 1992-08-19 GR GR920401764T patent/GR3005443T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3005443T3 (enExample) | 1993-05-24 |
| US4868168A (en) | 1989-09-19 |
| EP0316815B1 (en) | 1992-05-27 |
| CA1326448C (en) | 1994-01-25 |
| JPH01153641A (ja) | 1989-06-15 |
| EP0316815A1 (en) | 1989-05-24 |
| DE3871494D1 (de) | 1992-07-02 |
| ATE76576T1 (de) | 1992-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3872354D1 (de) | Steroidcreme. | |
| ES2184866T3 (es) | Composicion de tampon para reactivos de dosificado inmunologico. | |
| EP0062000A3 (en) | Use of 4-aminosalicylic acid as an anti-inflammatory agent | |
| DE3871965D1 (de) | Steroid-5-alpha-reduktase-inhibitoren. | |
| ES8308212A1 (es) | Un procedimiento de preparacion de una composicion farmaceutica topica que contiene un agente antimicrobiano de acido graso. | |
| AU5874580A (en) | 6beta,7beta,15,16-dimethylene-1,4-androstadien-3-ones | |
| ES2037742T3 (es) | Procedimiento de obtencion de una composicion para administracion intravenosa. | |
| ES2085345T3 (es) | Mejora de las funciones reproductoras en mamiferos | |
| FI854167A0 (fi) | Mun- och tandvaordsmedel. | |
| DE3871494D1 (de) | Steroidsalbe. | |
| KR860001831A (ko) | 비타민 d₃유도체의 제조방법 | |
| FI854179L (fi) | Antibakterieblandning och framstaellningsfoerfarande foer dess aktiva aemnen. | |
| AR240858A2 (es) | Una composicion fungicida | |
| DE3579193D1 (de) | Estriolester. | |
| AU578295B2 (en) | Phenyl-substituted naphthyridines and their use as anti-ulcer drugs | |
| ES482420A1 (es) | Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina. | |
| OA07904A (fr) | Composition nutritive de l'acide alpha-cétois un de ses sels. | |
| ES546995A0 (es) | Procedimiento para la preparacion de derivados de pregnano | |
| GR3004059T3 (enExample) | ||
| GB2042124B (en) | Reducing end float of shafts | |
| NO842887L (no) | Fremgangsmaate for fremstilling av 15,16-methylen-17alfa-pregna-4,6-dien-21-carboxylsyresalter | |
| ES8505677A1 (es) | Procedimiento para la preparacion del citrato de la (+) vinpocetina | |
| IT1222864B (it) | Preparati cosmetici liposomiali | |
| IT1222863B (it) | Derivati naturali ad attivita' biologica | |
| RO83933B1 (ro) | Produs hormonal cu actiune topica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 316815 Country of ref document: ES |